Dataset Information


Successful eradication of established peritoneal ovarian tumors in SCID-Beige mice following adoptive transfer of T cells genetically targeted to the MUC16 antigen.

ABSTRACT: Most patients diagnosed with ovarian cancer will ultimately die from their disease. For this reason, novel approaches to the treatment of this malignancy are needed. Adoptive transfer of a patient's own T cells, genetically modified ex vivo through the introduction of a gene encoding a chimeric antigen receptor (CAR) targeted to a tumor-associated antigen, is a novel approach to the treatment of ovarian cancer.We have generated several CARs targeted to the retained extracellular domain of MUC16, termed MUC-CD, an antigen expressed on most ovarian carcinomas. We investigate the in vitro biology of human T cells retrovirally transduced to express these CARs by coculture assays on artificial antigen-presenting cells as well as by cytotoxicity and cytokine release assays using the human MUC-CD(+) ovarian tumor cell lines and primary patient tumor cells. Further, we assess the in vivo antitumor efficacy of MUC-CD-targeted T cells in SCID-Beige mice bearing peritoneal human MUC-CD(+) tumor cell lines.CAR-modified, MUC-CD-targeted T cells exhibited efficient MUC-CD-specific cytolytic activity against both human ovarian cell and primary ovarian carcinoma cells in vitro. Furthermore, expanded MUC-CD-targeted T cells infused through either i.p. injection or i.v. infusion into SCID-Beige mice bearing orthotopic human MUC-CD(+) ovarian carcinoma tumors either delayed progression or fully eradicated disease.These promising preclinical studies justify further investigation of MUC-CD-targeted T cells as a potential therapeutic approach for patients with high-risk MUC16(+) ovarian carcinomas.

SUBMITTER: Chekmasova AA 

PROVIDER: S-EPMC2907178 | BioStudies | 2010-01-01

REPOSITORIES: biostudies

Similar Datasets

2015-01-01 | S-EPMC4404840 | BioStudies
2015-01-01 | S-EPMC4438636 | BioStudies
1000-01-01 | S-EPMC4388147 | BioStudies
2015-01-01 | S-EPMC4651718 | BioStudies
2008-01-01 | S-EPMC2593124 | BioStudies
1000-01-01 | S-EPMC6213745 | BioStudies
2009-01-01 | S-EPMC2650410 | BioStudies
2014-01-01 | S-EPMC5568695 | BioStudies
2009-01-01 | S-EPMC5548385 | BioStudies
1000-01-01 | S-EPMC3903436 | BioStudies